Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 16:22:10.
doi: 10.1186/s40409-016-0066-7. eCollection 2016.

Retrospective study on the incidence of envenomation and accessibility to antivenom in Burkina Faso

Sandrine Gampini  1 , Sonia Nassouri  1 , Jean-Philippe Chippaux  2 , Rasmané Semde  3
Affiliations

Retrospective study on the incidence of envenomation and accessibility to antivenom in Burkina Faso

Sandrine Gampini et al. J Venom Anim Toxins Incl Trop Dis. .

Abstract

Background: Snakebite is a common neglected public health issue, especially in poor rural areas of sub-Saharan Africa, Asia and Latin America. Passive immunotherapy with safe and effective antivenom is the only approved treatment for it. This study aimed to determine the incidence of snakebites, and to assess the availability and accessibility of antivenoms, from 2010 to 2014, in Burkina Faso.

Methods: The assessment of snakebite cases managed in all health facilities from 2010 to 2014 was performed from the Statistical Yearbook of the Ministry of Health. Antivenom consumption data were collected from the drug wholesalers established in Burkina Faso.

Results: Snakebites are among the five leading causes of consultations in health districts. From 2010 to 2014, 114,126 envenomation cases occurred in Burkina Faso, out of which 62,293 (54.6 %) victims have been hospitalized resulting in 1,362 (2 %) deaths. The annual incidence and mortality were respectively 130 bites and 1.75 deaths per 100,000 inhabitants. The amount of antivenom sold by wholesalers were 5,738 vials with a total cost of US$ 539,055 (annual average = US$ 107,811). The high cost of these antivenoms (between US$ 42 and 170 per dose according to brand) limited their use by rural people, the main victims of snakebites, whose income is insufficient. Thus, only 4 % of patients received antivenom treatment over the past five years. The price of antivenom was reduced in 2015 to US$ 3.4 by a public drug wholesaler.

Conclusion: The study confirmed the high burden of snakebites in Burkina Faso. To better manage envenomation, Burkina Faso implemented a strategy consisting in seeking affordable sources of antivenom supply of good quality and innovative mechanisms of subsidy.

Keywords: Antivenom; Burkina Faso; Envenomation; Snakebite.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Annual specific incidence of snakebites per 100,000 people according to the age group
Fig. 2
Fig. 2
Geographic distribution of snakebites in Burkina Faso (annual mean incidence per 100,000 population)
See this image and copyright information in PMC

References

    1. Chippaux JP. The treatment of snakebites: analysis of requirements and assessment of therapeutic efficacy in tropical Africa. In: Ménez A, editor. Perspectives in molecular toxinology. Chichester: John Wiley, Sons, Ltd; 2002. pp. 457–72.
    1. Roman B. Serpent de Haute Volta. Ouagadougou: Centre Nationale de Recherche en Science et Technologie; 1980. p. 130.
    1. Stock RP, Massougbodji A, Alagón A, Chippaux JP. Bringing antivenoms to Sub-Saharan Africa. Nature Biotechnol. 2007;25:173–7. doi: 10.1038/nbt0207-173. - DOI - PubMed
    1. Chippaux JP. Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approach. Toxicon. 2011;57(4):586–9. doi: 10.1016/j.toxicon.2010.12.022. - DOI - PubMed
    1. Chippaux JP. Estimating the global burden of snakebite can help to improve management. PLoS Med. 2008;5:221. doi: 10.1371/journal.pmed.0050221. - DOI - PMC - PubMed

LinkOut - more resources